The Synthesis of N-Morphine Hapten and Production of Monoclonal Antibody

The drug overdose and addiction is a serious international problem. Therefore developing a rapid, accurate, convenient and cheap method for detecting morphine in urea is useful and necessary, especially for investigation of epidemiology, identification of medical jurisprudence and determination of drug addict etc. There are many compounds that are similar to morphine in chemical structure and tend to have cross-reaction with the anti-morphine antibody. In order to reduce the cross reaction a…     

癌胚抗原毛细管电泳-化学发光均相免疫分析

建立了一种测定人血清中癌胚抗原的毛细管电泳-化学发光检测的均相免疫分析新方法.采用四苯硼钠增强luminol-H2 O2-HRP体系化学发光的原理,化学发光检测经毛细管电泳分离的,用辣根过氧化物酶(HRP)标记的癌胚抗体及免疫复合物.测定癌胚抗原的线性范围2.0～80.0 μg/L(R=0.9921),检出限为0.1 μg/L(绝对检出限为0.75 fg).     

水中硝基苯胺类化合物酶免疫化学分析技术研究

采用戊二醛法, 将4-硝基苯乙胺与牛血清蛋白(BSA)和卵清蛋白(OVA)共价偶联, 分别合成了免疫原4-硝基苯乙胺-BSA和包被原4-硝基苯乙胺-OVA, 经紫外分光光度计及飞行时间质谱扫描鉴定. 用合成的免疫抗原免疫新西兰大白兔, 并用合成的包被原进行间接竞争酶联免疫(ELISA)试验, 获得的抗血清效价达1∶32000. 方阵实验确定了包被抗原最佳浓度(0.5 mg/L)及抗血清最佳稀释度(1∶6000), 并建立了间接竞争ELISA方法. 工作曲线表明在1～1000 μg/L浓度范围内呈良好的线性关系, 该法IC₅₀值为(52.73±2.67) μg/L, 检测限为5.12 μg/L. 其它类似结构不干扰硝基苯胺的测定. 成功地建立了硝基苯胺类化合物的间接竞争酶免疫化学分析方法．     

巯基丁二胺铜单层修饰金电极上HIV-p24抗原的电化学免疫检测

制备了用巯基丁二胺铜(CuL)修饰的金电极并用作HIV-p24抗原蛋白(简称p24)免疫检测的化学传感器。CuL通过单层自组装固定在金电极表面,其覆盖率为1.02×10-11mol.cm-2,在含有1.0 mmol.L-1过氧化氢并在pH 6.2的磷酸盐缓冲溶液中,制备的校正曲线的线性范围为0.5-150μg.L-1p24对相应的伏安响应,方法的检出限为0.2μg.L-1。在10μg.L-1p24浓度水平作精密度试验,得RSD值为3.5%,于试样中分别加入5,15,20及30μg.L-1p24进行回收率试验,所得结果在98%-102%之间。此方法毋需另加电子传递媒介体。应用此方法于临床血清分析,所得结果与放射性免疫法的结果一致,且所得RSD值均小于0.3%。     

Establishment of a Tumor-bearing Mouse Model Stably Expressing EGFP Labeled Human MUC1 VNTRs

Two eukaryotic vectors expressing 9 tandem repeats of human MUCI（VNTR）, VR1012-VNTR, and pEGFP-VNTR, were constructed by cloning VNTR gene into VR1012 and pEGFP, respectively. VNTR stably expressing murine Lewis lung carcinoma（LLC） cell line（VNTR^＋ LLC） was established by Lipofectamine-mediated transfection of pEGFP-VNTR into LLC cells. The EGFP expression was observed under a fluorescent microscope and VNTR expression in VNTR^＋ LLC cells was confirmed by means of Western blotting. A syngenic graft tumor model was generated by subcutaneous injection of VNTR^＋ LLC cells into C57/BL6 mice and tumor size increased rapidly with time and in a cell qumber dependent manner. VNTR mRNA expression in the tumor formed was confirmed by RT-PCR. After the third immunization mice were challenged subcutaneously with 5×10^5 VNTR^＋ LLC cells, a significant reduction of subcutaneous tumor growth was observed in the groups immunized with VNTR plasmid DNA compared with that in the groups immunized with the vector DNA alone. Thus, the suppression of subcutaneous tumor was antigen-specific. This model is useful for the development of tumor vaccines targeting MUCI VNTRs.     

双酚A人工抗原的光谱表征及免疫鉴定研究

双酚A(bisphenol A,BPA)是一种酚类环境雌激素,即使极低剂量残留对人类健康也有危害。为了建立其简单快速并适应现场检测的免疫分析方法,必须先合成它的人工抗原并进行鉴定。通过对双酚A进行结构修饰,用碳二亚胺将结构修饰了的双酚A与牛血清蛋白相偶联,经透析得到纯的双酚A人工抗原并冷冻干燥备用。然后用紫外光谱、红外光谱和免疫方法对人工抗原进行鉴定。结果表明,合成的人工抗原紫外光谱图中具有蛋白质和双酚A的特征吸收峰;人工抗原红外光谱图中呈现双酚A和牛血清蛋白的红外特征吸收峰;通过竞争ELISA试验表明用合成的人工抗原免疫的Balb/c小鼠血清中产生了双酚A的抗体。三种方法综合鉴定结果表明双酚A人工抗原合成成功,该人工抗原可以进一步用于制备抗双酚A的单克隆抗体。     

基于聚硫堇、DNA/纳米银复合物共修饰癌胚抗原免疫传感器的研究

将硫堇聚合到玻碳电极(GCE)表面形成带正电的多孔聚硫堇(PTH)复合膜, 通过静电吸附固定DNA/纳米银复合物, 利用复合物中纳米银大的比表面积和强的吸附能力将癌胚抗体(anti-CEA)固定到电极表面, 从而制得高灵敏的电流型癌胚抗原(CEA)免疫传感器. 通过循环伏安法考察了电极表面的电化学行为, 并对免疫传感器的性能进行了详细研究. 在最优的实验条件下, 用示差脉冲伏安法(DPV)对癌胚抗原进行检测, 其线性范围为1.0～10.0 ng•mL^－1和10.0～80.0 ng•mL^－1, 线性相关系数分别为0.9983和0.9970, 检测限为0.24 ng•mL^－1, 并将该免疫传感器用于血清样品中CEA的检测.     

基于纳米金与碳纳米管-纳米铂-壳聚糖纳米复合物固定癌胚抗原免疫传感器的研究

采用纳米金(nano-Au)、多壁碳纳米管-纳米铂-壳聚糖的纳米复合物(MWNT-Pt-CS)及电子媒介体硫堇(Th)固载抗体制得高灵敏癌胚抗原免疫传感器．首先, 于壳聚糖溶液中用NaBH4还原H2PtCl6, 并将多壁碳纳米管分散于其中制得碳纳米管-纳米铂-壳聚糖纳米复合物, 并将其滴涂在玻碳电极上成膜; 然后, 吸附电子媒介体硫堇制得硫堇/碳纳米管-纳米铂-壳聚糖(Th/MWNT-Pt-CS)修饰电极．利用壳聚糖和硫堇分子中大量的氨基固定纳米金并吸附癌胚抗体(anti-CEA); 最后, 用辣根过氧化物酶(HRP)封闭活性位点从而制得高灵敏电流型免疫传感器．在优化的实验条件下, 该传感器响应的峰电流值与癌胚抗原(carcinoembryonic antigen)浓度在0.5～10和10～120 ng/mL的范围内保持良好的线性关系, 检测限为0.2 ng/mL．     

纳米孔技术对PD-1抗原抗体结合检测的实验研究

肿瘤的免疫疗法是利用人体自身的免疫系统去治疗肿瘤的一种方法，程序性死亡受体1（PD-1）是肿瘤免疫疗法中的一种免疫检查点，利用PD-1或PD-L1的单克隆抗体，可以阻断PD-1/PD-L1信号通路，恢复T细胞的免疫杀伤功能，实现肿瘤的免疫治疗.为了研究PD-1抗体药物与人体PD-1抗原的结合有效性，以PD-1蛋白质分子为实验对象，用纳米孔传感器件开展了PD-1、PD-1抗体及其结合物的辨识.分别对纯PD-1蛋白质分子和其抗体分子进行了纳米孔过孔实验研究，发现PD-1及其抗体的相对堵塞电流幅值比分别为0.00404和0.01297，实现了抗原抗体分子的区分.并对Si₃N₄纳米孔内壁进行了PD-1抗体修饰，再将PD-1蛋白质分子通过经抗体修饰后的纳米孔，以期实现结合物的检测，实验结果显示部分抗原抗体实现了特异性结合，剩下部分呈游离状，所以纳米孔技术可实现抗原抗体结合物的区分.未来，纳米孔有望成为无标志检测药物有效性的一种新手段.     

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine

We describe the use of capillary electrophoresis (CE) coupled with mass spectrometry (MS) to identify single polypeptides and patterns of polypeptides specific for prostate cancer (CaP) in human urine. Using improved sample preparation methods that enable enhanced comparability between different samples, we examined samples from 47 patients who underwent prostate biopsy. Of this group, 21 patients had benign pathology and 26 with CaP, and these were used to define potential biomarkers, which allow discrimination between these two states. In addition, CE-MS data from these 47 urine samples were compared to that of 41 young men (control) without known or suspected clinical CaP to further confirm the polypeptides indicative for CaP. Upon crossvalidation of the same samples, several polypeptides were selected that enabled correct classification of the CaP patients with 92% sensitivity and 96% specificity. We then examined an additional 474 samples from patients with renal disease enrolled in other studies and found that 14 (3%) had polypeptides suggestive of CaP possibly indicating that they harbor clinical CaP. In conclusion, this early pilot study suggests that CE-MS of urine warrants further investigation as a tool that can identify putative biomarkers for CaP.